Therapeutic potential of FAPI RLT in oncology: A systematic review
Saad Ruzzeh, Ahmed Saad Abdlkadir, Diana Páez, Keon Wook Kang, Tadashi Watabe, Serin Moghrabi, Andrew M. Scott, Akram Al‐Ibraheem
Abstract
FAPI RLT is a promising and safe therapeutic agent in oncology, with potential benefits achieved on short-term basis. However, its long-term efficacy and safety require further research with larger, controlled studies, considering the currently observed variations in patient populations, cancer types, and methodologies within reviewed studies.
Topics & Concepts
MedicineOncologyInternal medicineUrologyPeptidase Inhibition and Analysis